DENDRON-02: Efficacy and Safety of Combined Dendritic Cell Vaccine CaTeVac Immunotherapy and Standard Chemotherapy in Patients with CNS Glial Tumors. First Results. Вопр. онкол. [Internet]. 2026 May 8 [cited 2026 Oct. 14];72(2):OF-2504. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/2-26-DENDRON-02